Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study.
about
Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and reviewInverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment.Adjuvant/Perioperative Therapy in Pancreatic and Periampullary Cancer.Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review.How to treat borderline resectable pancreatic cancer: current challenges and future directions.Medical oncology and pancreatic cancer: what the radiologist needs to know.The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice?Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting.Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer.
P2860
Q33750803-FA87DA20-9E85-45FA-AF13-4839E855D549Q33751263-1CE46BA7-0718-4A7B-9CED-7657831F079AQ36159880-948989E3-2491-45F3-8DEA-ABD519E09BC3Q36195812-3228C2F2-04A9-4A02-8E08-42B474594A09Q36400058-3F1EDFDF-A40B-4882-9331-D531AA8C1C64Q38566193-916F42FE-19F8-4509-9662-CD8E30433FE6Q38905077-C0108C10-4E2A-4A5A-B2A1-01769A3E3E6DQ42374126-806AF5DC-7EBD-4C12-A5EB-B72190105EC9Q47163065-31371C2D-782B-4CCC-B827-F7241FAD0299Q47728528-990921B9-1645-4D44-8FC8-59954B2192B8Q49504793-4C192946-A8A2-4461-85CA-4C574A25E6FAQ49507783-5BA776BA-B5B1-422E-824A-0375DCCE1EF7Q50853969-3C54C047-52F0-43C2-BCC0-0302DC06A0D7Q53352724-B74630A6-43F6-493E-B76E-339C79636A09Q55190760-AEB5CDB3-5466-44C3-A293-3A79ADE4C361
P2860
Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Neoadjuvant FOLFIRINOX applica ...... a retrospective cohort study.
@ast
Neoadjuvant FOLFIRINOX applica ...... a retrospective cohort study.
@en
type
label
Neoadjuvant FOLFIRINOX applica ...... a retrospective cohort study.
@ast
Neoadjuvant FOLFIRINOX applica ...... a retrospective cohort study.
@en
prefLabel
Neoadjuvant FOLFIRINOX applica ...... a retrospective cohort study.
@ast
Neoadjuvant FOLFIRINOX applica ...... a retrospective cohort study.
@en
P2093
P2860
P1433
P1476
Neoadjuvant FOLFIRINOX applica ...... a retrospective cohort study.
@en
P2093
Alessandro Paniccia
Barish H Edil
Cheryl Meguid
Csaba Gajdos
Joshua T Byers
Martin D McCarter
Richard D Schulick
P2860
P356
10.1097/MD.0000000000000198
P407
P577
2014-12-01T00:00:00Z